[go: up one dir, main page]

BR0009778A - Composições antifúngicas de pseudomicina e métodos para utilização das mesmas - Google Patents

Composições antifúngicas de pseudomicina e métodos para utilização das mesmas

Info

Publication number
BR0009778A
BR0009778A BR0009778-0A BR0009778A BR0009778A BR 0009778 A BR0009778 A BR 0009778A BR 0009778 A BR0009778 A BR 0009778A BR 0009778 A BR0009778 A BR 0009778A
Authority
BR
Brazil
Prior art keywords
pseudomycin
methods
compositions
antifungal compositions
antifungal
Prior art date
Application number
BR0009778-0A
Other languages
English (en)
Inventor
Thomas Warren Jones
Michael John Rodriguez
Stephanie Ann Sweetana
Venkatraghavan Vasudevan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR0009778A publication Critical patent/BR0009778A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: "COMPOSIçõES ANTIFúNGICAS DE PSEUDOMICINA E MéTODOS PARA UTILIZAçãO DAS MESMAS". São descritos métodos e composições para o tratamento de infecções fúngicas que incluem formulações de uma pseudomicina ou de um agente antifúngico relacionado e de uma ciclodextrina. As composições são particularmente úteis em aplicações farmacêuticas para reduzir efeitos adversos.
BR0009778-0A 1999-04-15 2000-04-14 Composições antifúngicas de pseudomicina e métodos para utilização das mesmas BR0009778A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12943599P 1999-04-15 1999-04-15
PCT/US2000/008725 WO2000062793A2 (en) 1999-04-15 2000-04-14 Pseudomycin antifungal compositions and methods for their use

Publications (1)

Publication Number Publication Date
BR0009778A true BR0009778A (pt) 2002-01-02

Family

ID=22439926

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009778-0A BR0009778A (pt) 1999-04-15 2000-04-14 Composições antifúngicas de pseudomicina e métodos para utilização das mesmas

Country Status (11)

Country Link
EP (1) EP1171150A2 (pt)
JP (1) JP2002542201A (pt)
CN (1) CN1360505A (pt)
AU (1) AU4328700A (pt)
BR (1) BR0009778A (pt)
CA (1) CA2371942A1 (pt)
EA (1) EA200101088A1 (pt)
HU (1) HUP0201048A3 (pt)
MX (1) MXPA01010247A (pt)
NO (1) NO20014988L (pt)
WO (1) WO2000062793A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034013B2 (en) * 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
BRPI0105509B8 (pt) * 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
DE10228049A1 (de) * 2002-06-24 2004-01-15 Merck Patent Gmbh Flüssige Zubereitung enthaltend Oligopeptide
JP5272126B2 (ja) * 2006-06-29 2013-08-28 リンク・ジェノミクス株式会社 抗生物質の注射剤及びその投与液
MY161597A (en) 2008-11-15 2017-04-28 Rib-X Pharmaceuticals Inc Antimicrobial compositions
TWI568365B (zh) * 2014-07-22 2017-02-01 蘇廷弘 抑菌複合物及其製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576298A (en) * 1992-11-30 1996-11-19 Research And Development Institute, Inc. At Montana State University Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity
US5830855A (en) * 1996-09-12 1998-11-03 Utah State University Lipodepsipeptides as antifungal and fungicidal agents

Also Published As

Publication number Publication date
EP1171150A2 (en) 2002-01-16
EA200101088A1 (ru) 2002-04-25
HUP0201048A3 (en) 2002-10-28
CN1360505A (zh) 2002-07-24
WO2000062793A3 (en) 2001-01-18
HUP0201048A2 (en) 2002-08-28
NO20014988L (no) 2001-12-03
NO20014988D0 (no) 2001-10-12
MXPA01010247A (es) 2002-03-27
CA2371942A1 (en) 2000-10-26
WO2000062793A2 (en) 2000-10-26
AU4328700A (en) 2000-11-02
JP2002542201A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
MX9505182A (es) Composicion terapeutica para aplicacion topica, que contiene un antagonista de la substancia p.
BR0211390A (pt) Tratamento de infecções da unha com no
BRPI0410260A (pt) composição conjugada para medicamento
BRPI0416160A (pt) composições de xampu antimicrobianas
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
AR015900A1 (es) Una formulacion farmaceutica que comprende voriconazol o un derivado farmaceuticamente aceptable del mismo y un derivado de ciclodextrina.
BRPI0515316A (pt) compostos de imidazoquinolina
BR0112461A (pt) Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
BRPI0208210B8 (pt) preparação de insulina pobre em zinco e isenta de zinco com estabilidade aperfeiçoada
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
WO2004089357A3 (en) Anti-fungal formulation of triterpene and essential oil
BR0014384A (pt) Compostos para o tratamento da isquémia
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
BR0112962A (pt) Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
BR0316170A (pt) Combinação, composição farmacêutica, uso de uma combinação, e, método para a profilaxia ou tratamento sinergìstico de câncer
DK0722313T3 (da) Viskoelastiske sammensætninger af fluorerede organiske forbindelser
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
DE60312211D1 (de) Haarbehandlungsmittel
FR2744017B1 (fr) Associations de lipides peroxydes et de composes organosiliciques, compositions cosmetiques et dermatologiques les contenant et leurs applications notamment pour le traitement de l'alopecie
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]